Joana Dinis

Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters<i>ABCB1, ABCC1, ABCG2, MVP, and SLC22A1</i>

Marta Gromicho, Joana Dinis, Marta Magalhães et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 65 citations

Drug Target, Mixed-phenotype Acute Leukemia, Dasatinib Resistance +17

Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas

Raquel Rodrigues, Lúcia Roque, Carla Espadinha et al. · Oncology Reports · 2007 · 47 citations · Full text

Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib

Marta Gromicho, Marta Magalhães, Fátima Torres et al. · Oncology Reports · 2012 · 42 citations · Full text

Who takes the lead in the development of ulcerative colitis–associated colorectal cancers: mutator, suppressor, or methylator pathway?

Lara Maia, Joana Dinis, Marília Cravo et al. · Cancer Genetics and Cytogenetics · 2005 · 20 citations

Colorectal Cancers, Gastrointestinal Oncology, Medicine +10

DNA damage response in imatinib resistant chronic myeloid leukemia K562 cells

Joana Dinis, Vânia Silva, Marta Gromicho et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 14 citations